Figure 5From: Src activity is modulated by oxaliplatin and correlates with outcomes after hepatectomy for metastatic colorectal cancer Overall survival according to relative expression of pFAK and pSrc (cohort 1, N = 120). A non-significant trend towards worse overall survival was noted in those patients with higher levels of pFAK and pSrc.Back to article page